These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21827558)

  • 1. Seroma is an expected consequence and not a complication of MammoSite brachytherapy.
    Patel PS; Yan W; Trichter S; Sabbas A; Rosenblatt R; Drotman MB; Swistel A; Chao KS; Nori D; Hayes MK
    Breast J; 2011; 17(5):498-502. PubMed ID: 21827558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors.
    Evans SB; Kaufman SA; Price LL; Cardarelli G; Dipetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):333-9. PubMed ID: 16545918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.
    Stecklein SR; Shaitelman SF; Babiera GV; Bedrosian I; Black DM; Ballo MT; Arzu I; Strom EA; Reed VK; Dvorak T; Smith BD; Woodward WA; Hoffman KE; Schlembach PJ; Kirsner SM; Nelson CL; Yang J; Guerra W; Dibaj S; Bloom ES
    Pract Radiat Oncol; 2019 Jan; 9(1):e4-e13. PubMed ID: 30125673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence.
    Ravi A; Lee S; Karsif K; Osian A; Nori D
    Brachytherapy; 2010; 9(1):76-80. PubMed ID: 19853537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.
    Watkins JM; Harper JL; Dragun AE; Ashenafi MS; Sinha D; Li J; Cole DJ; Jenrette JM
    Brachytherapy; 2008; 7(4):305-9. PubMed ID: 18778970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator.
    Dickler A; Kirk MC; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Shott S; Nguyen C
    Breast J; 2005; 11(5):306-10. PubMed ID: 16174149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
    Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
    Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M; Hall M; Julian TB
    Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.
    Cuttino LW; Arthur DW; Vicini F; Todor D; Julian T; Mukhopadhyay N
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1025-9. PubMed ID: 25442036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of complication rates in early-stage breast cancer patients treated with brachytherapy versus whole-breast irradiation.
    Ajkay N; Collett AE; Bloomquist EV; Gracely EJ; Frazier TG; Barrio AV
    Ann Surg Oncol; 2015 Apr; 22(4):1140-5. PubMed ID: 25319575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience.
    Guenzi M; Giannelli F; Azinwi C; Ricchetti F; Vagge S; Canavese G; Massa T; Garelli S; Carli F; Corvò R
    Breast J; 2009; 15(6):603-9. PubMed ID: 19995379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
    Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
    Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.